SG/PUT/NOVO-NORDISK B/950/0.1/20.09.24 Share Price

Warrant

DE000SU9ACA0

Market Closed - Bid/Ask 07:14:16 03/07/2024 BST After market 20:05:59
0.54 EUR +8.00% Intraday chart for SG/PUT/NOVO-NORDISK B/950/0.1/20.09.24 0.735 +36.11%
Current month-1.96%
1 month-51.46%
Date Price Change
03/07/24 0.54 +8.00%
02/07/24 0.5 -1.96%
01/07/24 0.51 0.00%
28/06/24 0.51 -1.92%
27/06/24 0.52 +10.64%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 07:14 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SU9ACA
ISINDE000SU9ACA0
Date issued 13/02/2024
Strike 950 kr
Maturity 20/09/2024 (79 Days)
Parity 10 : 1
Emission price 2.06
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.2
Lowest since issue 0.47
Delta0x
Omega 0.000000
Premium0x
Gearing17.63x
Moneyness 0.9819
Difference Strike -17.5 kr
Difference Strike %-1.84%
Spread 0.05
Spread %6.58%
Intrinsic value 0.000000
Present value 0.7350

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus